Skilled Nursing Facilities

Nursing home medication compliance is now an active federal target.

 

In 2026 the HHS Office of Inspector General opened a new audit of opioid controls in nursing homes and published two reports on antipsychotic misuse. I help skilled nursing and long-term care facilities tighten controlled-substance controls, modernize outdated policies, and ready their nursing teams — before surveyors arrive, not after the citation.  (See more here: Implementation and Effectiveness of Nursing Home Pharmacy Service Internal Controls to Prevent Opioid Overuse, Misuse, and Diversion. Work Plan, Project No. OAS-26-01-027.)

​

What the OIG Will Examine

​

On the Reviewer's Checklist:

• Prescribing patterns and how long residents stay on opioid therapy

• Documentation of a specific indication and real functional benefit

• Consultant pharmacist oversight

• Facility-level diversion prevention systems

• State survey agency monitoring

• Potential Medicare and Medicaid billing implications

​

Surveyors will read opioid practice through the same tags they already use: F689 (accident hazards / sedation-related falls), F758 (unnecessary drugs — indication, dose, duration), F761 (drug storage and diversion safeguards), and F755 (pharmacy services). Unlike antipsychotics, opioids carry no mandated dose-reduction rule — but surveyors increasingly expect pain assessment, non-opioid options trialed where appropriate, and ongoing benefit-versus-harm reassessment.

​

Where Diversion Actually Happens

​

The Handling Chain

​

A controlled substance passes through many hands before a resident takes it. Unlike an outpatient pharmacy, a skilled nursing facility moves every dose through prescriber, pharmacy, delivery, medication-room storage, nurse administration, and waste documentation. Each handoff is a place a control can fail — and the failures show up in predictable spots.

​

Common vulnerabilities:

• Incomplete or unwitnessed waste

• PRN discrepancies

• Delayed reconciliation after a discharge or death

• Medication Administration Records (with paper MARs being the most vulnerable)

​

Most of these are nursing-side controls. They're also exactly what an OIG data request will ask you to prove.

​

The Documentation Bar Just Rose

​

The records a reviewer expects to find — complete, consistent, and written in real time

​

• A specific diagnosis behind every opioid, not just a pain score

• The functional impact the medication is meant to address

• Defined reassessment intervals

• Side-effect monitoring that actually happened

• A documented risk-versus-benefit rationale

​

OIG audits routinely request claims data, consultant pharmacist reports, incident logs, medication-error records, and controlled-substance reconciliation logs — and they check whether those records line up with one another. Gaps and inconsistencies are what get flagged.

​

How I Help You Get Ahead of It

​

Nursing-side readiness, built before the audit — not after

​

What that looks like:

• An internal walk-through of controlled-substance handling: counts, witnessed waste, storage, access, and reconciliation

• Review of PRN patterns and post-discharge/death reconciliation for the discrepancies auditors look for

• Documentation standards your nurses can actually meet on a shift — indication, monitoring, reassessment

• Help building or updating a written opioid stewardship policy, including a diversion-reporting pathway

• Staff education with competency testing and certificates for your compliance files

 

Relief of suffering and regulatory compliance aren't opposing goals. Both come from the same thing: disciplined systems and a well-trained nursing team.